Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The collaboration aims to discover and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer by leveraging etherna’s innovative mRNA/LNP technology platform and LNP formulations with Almirall’s leading expertise in dermatology.
Lead Product(s): mRNA-based Therapy
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: DiscoveryProduct Type: Large molecule
Partner/Sponsor/Collaborator: Almirall
Deal Size: $327.0 million Upfront Cash: Undisclosed
Deal Type: Collaboration December 12, 2023